Featured Research

from universities, journals, and other organizations

Isoflavone Genistein May Negate Effect Of Common Breast Cancer Drug

Date:
May 10, 2002
Source:
University Of Illinois At Urbana-Champaign
Summary:
Isoflavone-enhanced dietary supplements containing genistein may negate the tumor-fighting effects of tamoxifen, a commonly prescribed medication for women battling estrogen-dependent breast cancer, according to new findings appearing in the May 1 issue of the journal Cancer Research.

CHAMPAIGN, Ill. — Isoflavone-enhanced dietary supplements containing genistein may negate the tumor-fighting effects of tamoxifen, a commonly prescribed medication for women battling estrogen-dependent breast cancer, according to new findings appearing in the May 1 issue of the journal Cancer Research.

The research was led by William G. Helferich, a professor of food science and human nutrition at the University of Illinois at Urbana-Champaign.

In a pre-clinical study, researchers divided 66 mice, with their ovaries removed, into six groups to monitor the effects of estrogen and various amounts of tamoxifen and genistein, an estrogen-like component found in legume plants. Estrogen and tamoxifen implants were put into the mice, and estrogen-dependent breast cancer cells were injected. Before adding genistein to the diet, the tamoxifen had stopped tumor growth. The addition of genistein resulted in enhanced growth of estrogen-dependent tumors and increases in estrogen-responsive gene markers.

Blood concentrations of genistein in these mice were similar to those levels that people can get by consuming isoflavone-rich dietary supplements, Helferich said.

"Previous studies in rodents have suggested that exposure to genistein early in life may prevent or delay breast cancer," Helferich said. However, in a series of studies published last year, Helferich's laboratory demonstrated that various dietary products containing genistein can stimulate the growth of estrogen-dependent human breast tumors implanted into adult mice.

"This new study takes our previous findings a step further," Helferich said. "These results raise concern about consuming dietary isoflavone supplements in conjunction with tamoxifen in postmenopausal women who have estrogen-dependent breast cancer."

"This study also applies to women who are self-medicating with dietary estrogenic supplements by showing the supplements could negate the protective benefit of tamoxifen," he added.

Postmenopausal women with estrogen-dependent breast cancer often face an emotional roller coaster. Physicians prescribe tamoxifen to suppress the tumors and recommend against the use of hormone-replacement therapy (HRT). While tamoxifen stops estrogen from stimulating breast cancer cells, it also can cause menopausal symptoms. Unknown to their physicians, some women turn to over-the-counter products containing isoflavones as an alternative to HRT to treat their menopausal symptoms.

Genistein often is identified as one of several desired isoflavones in soy products, including soy-enhanced drinks and dietary supplements. Dietary isoflavones also can be found in both subterranean and red clover supplements.

Isoflavones in soy are believed to be responsible for anti-cancer effects observed in numerous human and animal studies. For example, in Asia, where cancer rates are low, people often consume diets rich in soy products that contain about 20 to 30 milligrams of isoflavones a day, Helferich said. However, many isoflavone-enhanced drinks and supplements now available in the United States may contain 30 to 150 milligrams per serving, and two or more servings a day are recommended on the labels, he added.

Other researchers contributing to the study were Young H. Ju, Kimberly F. Allred and Clinton D. Allred, all of the department of food science and human nutrition at Illinois, and Daniel R. Doerge of the National Center for Toxicological Research in Jefferson, Ark.

The National Institutes of Health funded the research through a grant to Helferich.


Story Source:

The above story is based on materials provided by University Of Illinois At Urbana-Champaign. Note: Materials may be edited for content and length.


Cite This Page:

University Of Illinois At Urbana-Champaign. "Isoflavone Genistein May Negate Effect Of Common Breast Cancer Drug." ScienceDaily. ScienceDaily, 10 May 2002. <www.sciencedaily.com/releases/2002/05/020509074102.htm>.
University Of Illinois At Urbana-Champaign. (2002, May 10). Isoflavone Genistein May Negate Effect Of Common Breast Cancer Drug. ScienceDaily. Retrieved August 31, 2014 from www.sciencedaily.com/releases/2002/05/020509074102.htm
University Of Illinois At Urbana-Champaign. "Isoflavone Genistein May Negate Effect Of Common Breast Cancer Drug." ScienceDaily. www.sciencedaily.com/releases/2002/05/020509074102.htm (accessed August 31, 2014).

Share This




More Health & Medicine News

Sunday, August 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
3 Things To Know About The Ebola Outbreak's Progression

3 Things To Know About The Ebola Outbreak's Progression

Newsy (Aug. 29, 2014) Here are three things you need to know about the deadly Ebola outbreak's progression this week. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins